Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial

Peter Holger Johnsen, Frederik Emil Juul, Dag Arne Lihaug Hoff, Eline Randulff Hillestad, Øyvind Holme, Linn Kallbekken Skjevling, Hege Marie Hansen, Marthe H Rasmus, Lauren Barnett, Sarah J E Barry, Erik Hjerde, Kenneth Lindstedt, Dorota J Buczek, Jan G Hatlebakk, Elisabeth K Steinsvik, Birgitte Berentsen, Kjetil Kjeldstad Garborg, Jørgen Valeur, Per Christian Valle, Magnus Løberg, Mette Kalager, Michael Bretthauer, Rasmus Goll

Open source

DOI
10.1016/s0140-6736(26)01424-8
Published
2026-09
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01424-8,
  title = {Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial},
  author = {Peter Holger Johnsen and Frederik Emil Juul and Dag Arne Lihaug Hoff and Eline Randulff Hillestad and Øyvind Holme and Linn Kallbekken Skjevling and Hege Marie Hansen and Marthe H Rasmus and Lauren Barnett and Sarah J E Barry and Erik Hjerde and Kenneth Lindstedt and Dorota J Buczek and Jan G Hatlebakk and Elisabeth K Steinsvik and Birgitte Berentsen and Kjetil Kjeldstad Garborg and Jørgen Valeur and Per Christian Valle and Magnus Løberg and Mette Kalager and Michael Bretthauer and Rasmus Goll},
  year = {2026},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(26)01424-8},
  url = {https://doi.org/10.1016/s0140-6736(26)01424-8}
}

RIS

TY  - JOUR
TI  - Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
AU  - Peter Holger Johnsen
AU  - Frederik Emil Juul
AU  - Dag Arne Lihaug Hoff
AU  - Eline Randulff Hillestad
AU  - Øyvind Holme
AU  - Linn Kallbekken Skjevling
AU  - Hege Marie Hansen
AU  - Marthe H Rasmus
AU  - Lauren Barnett
AU  - Sarah J E Barry
AU  - Erik Hjerde
AU  - Kenneth Lindstedt
AU  - Dorota J Buczek
AU  - Jan G Hatlebakk
AU  - Elisabeth K Steinsvik
AU  - Birgitte Berentsen
AU  - Kjetil Kjeldstad Garborg
AU  - Jørgen Valeur
AU  - Per Christian Valle
AU  - Magnus Løberg
AU  - Mette Kalager
AU  - Michael Bretthauer
AU  - Rasmus Goll
PY  - 2026
JO  - The Lancet
DO  - 10.1016/s0140-6736(26)01424-8
UR  - https://doi.org/10.1016/s0140-6736(26)01424-8
ER  - 

APA

Johnsen, P. H., Juul, F. E., Hoff, D. A. L., Hillestad, E. R., Holme, Ø., Skjevling, L. K., Hansen, H. M., Rasmus, M. H., Barnett, L., Barry, S. J. E., Hjerde, E., Lindstedt, K., Buczek, D. J., Hatlebakk, J. G., Steinsvik, E. K., Berentsen, B., Garborg, K. K., Valeur, J., Valle, P. C., Løberg, M., Kalager, M., Bretthauer, M., & Goll, R. (2026). Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(26)01424-8

Source records